Gastroenterology
Volume 130, Issue 7 , Pages 2023-2030 , June 2006

Association of Cardiorespiratory Fitness, Body Mass Index, and Waist Circumference to Nonalcoholic Fatty Liver Disease

  • Timothy S. Church

      Affiliations

    • The Cooper Institute, Dallas, Texas
    • Corresponding Author InformationAddress requests for reprints to: Timothy S. Church, MD, The Cooper Institute, 12330 Preston Road, Dallas, Texas 75230. fax: (972) 341-3221
    • ,
  • Jennifer L. Kuk

      Affiliations

    • School of Physical and Health Education, Queen’s University, Kingston, Ontario, Canada
    • ,
  • Robert Ross

      Affiliations

    • School of Physical and Health Education, Queen’s University, Kingston, Ontario, Canada
    • ,
  • Elisa L. Priest

      Affiliations

    • The Cooper Institute, Dallas, Texas
    • ,
  • Emily Biltoff

      Affiliations

    • Texas Tech University School of Medicine, Lubbock, Texas
    • ,
  • Steven N. Blair

      Affiliations

    • The Cooper Institute, Dallas, Texas

Received 10 October 2005 ,Accepted 22 February 2006.

References 

  1. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis (Mayo Clinic experiences with a hitherto unnamed disease). Mayo Clin Proc. 1980;55:434–438
  2. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221–1231
  3. Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology. 2002;122:1649–1657
  4. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis (summary of an AASLD Single Topic Conference). Hepatology. 2003;37:1202–1219
  5. Te SK, Bourass I, Sels JP, Driessen A, Stockbrugger RW, Koek GH. Non-alcoholic steatohepatitis (review of a growing medical problem). Eur J Intern Med. 2004;15:10–21
  6. Festi D, Colecchia A, Sacco T, Bondi M, Roda E, Marchesini G. Hepatic steatosis in obese patients (clinical aspects and prognostic significance). Obes Rev. 2004;5:27–42
  7. Reid AE. Nonalcoholic steatohepatitis. Gastroenterology. 2001;121:710–723
  8. Yu AS, Keeffe EB. Nonalcoholic fatty liver disease. Rev Gastroenterol Disord. 2002;2:11–19
  9. Luyckx FH, Desaive C, Thiry A, Dewe W, Scheen AJ, Gielen JE, et al. Liver abnormalities in severely obese subjects (effect of drastic weight loss after gastroplasty). Int J Obes Relat Metab Disord. 1998;22:222–226
  10. Youssef WI, McCullough AJ. Steatohepatitis in obese individuals. Best Pract Res Clin Gastroenterol. 2002;16:733–747
  11. Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C, et al. NASH and insulin resistance (insulin hypersecretion and specific association with the insulin resistance syndrome). Hepatology. 2002;35:373–379
  12. Ruhl CE, Everhart JE. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology. 2003;124:71–79
  13. Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med. 2000;132:112–117
  14. Rinella ME, Alonso E, Rao S, Whitington P, Fryer J, Abecassis M, et al. Body mass index as a predictor of hepatic steatosis in living liver donors. Liver Transplantation. 1993;42:548–551
  15. Walsh MC, Hunter GR, Sirikul B, Gower BA. Comparison of self-reported with objectively assessed energy expenditure in black and white women before and after weight loss. Am J Clin Nutr. 2004;79:1013–1019
  16. Blair SN, Goodyear NN, Gibbons LW, Cooper KH. Physical fitness and incidence of hypertension in healthy normotensive men and women. JAMA. 1984;252:487–490
  17. Blair SN, Kohl HW, Paffenbarger RS, Clark DG, Cooper KH, Gibbons LW. Physical fitness and all-cause mortality (a prospective study of healthy men and women). JAMA. 1989;262:2395–2401
  18. Blair SN, Kohl HW, Barlow CE, Paffenbarger RS, Gibbons LW, Macera CA. Changes in physical fitness and all-cause mortality (a prospective study of healthy and unhealthy men). JAMA. 1995;273:1093–1098
  19. Nguyen-Duy TB, Nichaman MZ, Church TS, Blair SN, Ross R. Visceral fat and liver fat are independent predictors of metabolic risk factors in men. Am J Physiol. 2003;284:E1065–E1072
  20. Wong SL, Katzmarzyk P, Nichaman MZ, Church TS, Blair SN, Ross R. Cardiorespiratory fitness is associated with lower abdominal fat independent of body mass index. Med Sci Sports Exerc. 2004;36:286–291
  21. Lee S, Kuk JL, Katzmarzyk PT, Blair SN, Church TS, Ross R. Cardiorespiratory fitness attenuates metabolic risk independent of abdominal subcutaneous and visceral fat in men. Diabetes Care. 2005;28:895–901
  22. Pollock ML, Bohannon RL, Cooper KH, Ayres JJ, Ward A, White SR, et al. A comparative analysis of four protocols for maximal treadmill stress testing. Am Heart J. 1976;92:39–46
  23. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (adult treatment panel III). JAMA. 2001;285:2486–2497
  24. McLaughlin T, Reaven G, Abbasi F, Lamendola C, Saad M, Waters D, et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?. Am J Cardiol. 2005;96:399–404
  25. Piekarski J, Goldberg HI, Royal SA, Axel L, Moss AA. Difference between liver and spleen CT numbers in the normal adult (its usefulness in predicting the presence of diffuse liver disease). Radiology. 1980;137:727–729
  26. Ricci C, Longo R, Gioulis E, Bosco M, Pollesello P, Masutti F, et al. Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol. 1997;27:108–113
  27. Jacobs JE, Birnbaum BA, Shapiro MA, Langlotz CP, Slosman F, Rubesin SE, et al. Diagnostic criteria for fatty infiltration of the liver on contrast-enhanced helical CT. AJR Am J Roentgenol. 1998;171:659–664
  28. de Knegt RJ. Non-alcoholic steatohepatitis (clinical significance and pathogenesis). Scand J Gastroenterol Suppl. 2001;234:88–92
  29. Joy D, Thava VR, Scott BB. Diagnosis of fatty liver disease (is biopsy necessary?). Eur J Gastroenterol Hepatol. 2003;15:539–543
  30. Prati D, Taioli E, Zanella A, Della TE, Butelli S, Del Vecchio E, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. 2002;137:1–10
  31. Mehta K, Van Thiel DH, Shah N, Mobarhan S. Nonalcoholic fatty liver disease (pathogenesis and the role of antioxidants). Nutr Rev. 2002;60:289–293
  32. National Institutes of Health. In: Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults (the evidence report). Rockville, MD: National Institutes of Health; 1998;p. 1–228
  33. Ross R, Dagnone D, Jones PJH, Smith H, Paddags A, Hudson R, et al. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men (a randomized, controlled trial). Ann Intern Med. 2000;133:92–103
  34. Kavanagh T, Mertens DJ, Hamm LF, Beyene J, Kennedy J, Corey P, et al. Peak oxygen intake and cardiac mortality in women referred for cardiac rehabilitation. J Am Coll Cardiol. 2003;42:2139–2143
  35. Wei M, Kampert JB, Barlow CE, Nichaman MZ, Gibbons LW, Paffenbarger RSJ, et al. Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men. JAMA. 1999;282:1547–1553
  36. Church TS, Cheng YJ, Earnest CP, Barlow CE, Gibbons LW, Priest EL, et al. Exercise capacity and body composition as predictors of mortality among men with diabetes. Diabetes Care. 2004;27:83–88
  37. Church TS, Barlow CE, Earnest CP, Kampert JB, Priest EL, Blair SN. Associations between cardiorespiratory fitness and C-reactive protein in men. Arterioscler Thromb Vasc Biol. 2002;22:1869–1876
  38. Katzmarzyk PT, Church TS, Janssen I, Ross R, Blair SN. Metabolic syndrome, obesity, and mortality (impact of cardiorespiratory fitness). Diabetes Care. 2005;28:391–397
  39. Kojda G, Hambrecht R. Molecular mechanisms of vascular adaptations to exercise. Physical activity as an effective antioxidant therapy?. Cardiovasc Res. 2005;67:187–197
  40. Westerbacka J, Lammi K, Hakkinen AM, Rissanen A, Salminen I, Aro A, et al. Dietary fat content modifies liver fat in overweight nondiabetic subjects. J Clin Endocrinol Metab. 2005;90:2804–2809
  41. Brodney S, McPherson RS, Carpenter RA, Welten D, Blair SN. Nutrient intake of physically fit and unfit men and women. Med Sci Sports Exerc. 2001;33:459–467
  42. Blair SN, Ellsworth NM, Haskell WL, Stern MP, Farquhar JW, Wood PD. Comparison of nutrient intake in middle-aged men and women runners and controls. Med Sci Sports Exerc. 1981;13:310–315
  43. Bouchard C. Genetics of aerobic power and capacity. In:  Malina RM,  Bouchard C editor. Sport and human genetics. Champaign, IL: Human Kinetics; 1986;p. 59–88
  44. Bouchard C, Pérusse L. Heredity, activity level, fitness, and health. In:  Bouchard C,  Shephard RJ,  Stephens T editor. Physical activity, fitness, and health (international proceedings and consensus statement). Champaign, IL: Human Kinetics Publishers; 1994;p. 106–118

 Supported in part by U.S. Public Health Service research grant AG06945 from the National Institute on Aging, and grant HL62508 from the National Heart, Lung, and Blood Institute.

PII: S0016-5085(06)00568-3

doi: 10.1053/j.gastro.2006.03.019

Gastroenterology
Volume 130, Issue 7 , Pages 2023-2030 , June 2006

Article Tools

* Image Usage & Resolution